348 related articles for article (PubMed ID: 21801834)
21. Solid-state plasticization of an acrylic polymer with chlorpheniramine maleate and triethyl citrate.
Zhu Y; Shah NH; Malick AW; Infeld MH; McGinity JW
Int J Pharm; 2002 Jul; 241(2):301-10. PubMed ID: 12100857
[TBL] [Abstract][Full Text] [Related]
22. Effect of two hydrophobic polymers on the release of gliclazide from their matrix tablets.
Hussain T; Saeed T; Mumtaz AM; Javaid Z; Abbas K; Awais A; Idrees HA
Acta Pol Pharm; 2013; 70(4):749-57. PubMed ID: 23923399
[TBL] [Abstract][Full Text] [Related]
23. Influence of additives on melt viscosity, surface tension, and film formation of dry powder coatings.
Sauer D; McGinity JW
Drug Dev Ind Pharm; 2009 Jun; 35(6):646-54. PubMed ID: 19337869
[TBL] [Abstract][Full Text] [Related]
24. Oscillatory Shear Rheology in Examining the Drug-Polymer Interactions Relevant in Hot Melt Extrusion.
Aho J; Edinger M; Botker J; Baldursdottir S; Rantanen J
J Pharm Sci; 2016 Jan; 105(1):160-7. PubMed ID: 26852851
[TBL] [Abstract][Full Text] [Related]
25. Continuous production of controlled release dosage forms based on hot-melt extruded gum arabic: Formulation development, in vitro characterization and evaluation of potential application fields.
Kipping T; Rein H
Int J Pharm; 2016 Jan; 497(1-2):36-53. PubMed ID: 26617317
[TBL] [Abstract][Full Text] [Related]
26. Preparation of lipid aspirin sustained-release pellets by solvent-free extrusion/spheronization and an investigation of their stability.
Yan X; He H; Meng J; Zhang C; Hong M; Tang X
Drug Dev Ind Pharm; 2012 Oct; 38(10):1221-9. PubMed ID: 22713120
[TBL] [Abstract][Full Text] [Related]
27. Preparation of sustained release matrix pellets by melt agglomeration in the fluidized bed: influence of formulation variables and modelling of agglomerate growth.
Pauli-Bruns A; Knop K; Lippold BC
Eur J Pharm Biopharm; 2010 Mar; 74(3):503-12. PubMed ID: 20026401
[TBL] [Abstract][Full Text] [Related]
28. Novel Controlled Release Polymer-Lipid Formulations Processed by Hot Melt Extrusion.
Maniruzzaman M; Islam MT; Halsey S; Amin D; Douroumis D
AAPS PharmSciTech; 2016 Feb; 17(1):191-9. PubMed ID: 26689407
[TBL] [Abstract][Full Text] [Related]
29. Use of the direct compression aid Ludiflash(®) for the preparation of pellets via wet extrusion/spheronization.
Roblegg E; Schrank S; Griesbacher M; Radl S; Zimmer A; Khinast J
Drug Dev Ind Pharm; 2011 Oct; 37(10):1231-43. PubMed ID: 21438702
[TBL] [Abstract][Full Text] [Related]
30. Dissolution from solid lipid extrudates containing release modifiers.
Güres S; Kleinebudde P
Int J Pharm; 2011 Jun; 412(1-2):77-84. PubMed ID: 21515350
[TBL] [Abstract][Full Text] [Related]
31. Solid lipid extrudates as sustained-release matrices: the effect of surface structure on drug release properties.
Reitz C; Strachan C; Kleinebudde P
Eur J Pharm Sci; 2008 Nov; 35(4):335-43. PubMed ID: 18765281
[TBL] [Abstract][Full Text] [Related]
32. Preparation of lovastatin matrix sustained-release pellets by extrusion-spheronization combined with microcrystal dispersion technique.
He H; Shi B; Cai C; Tang X
Arch Pharm Res; 2011 Nov; 34(11):1931-8. PubMed ID: 22139692
[TBL] [Abstract][Full Text] [Related]
33. Characterization of thermal and rheological properties of zidovudine, lamivudine and plasticizer blends with ethyl cellulose to assess their suitability for hot melt extrusion.
Maru SM; de Matas M; Kelly A; Paradkar A
Eur J Pharm Sci; 2011 Nov; 44(4):471-8. PubMed ID: 21925600
[TBL] [Abstract][Full Text] [Related]
34. Development of sustained and dual drug release co-extrusion formulations for individual dosing.
Laukamp EJ; Vynckier AK; Voorspoels J; Thommes M; Breitkreutz J
Eur J Pharm Biopharm; 2015 Jan; 89():357-64. PubMed ID: 25555454
[TBL] [Abstract][Full Text] [Related]
35. Citric acid as a solid-state plasticizer for Eudragit RS PO.
Schilling SU; Shah NH; Malick AW; Infeld MH; McGinity JW
J Pharm Pharmacol; 2007 Nov; 59(11):1493-500. PubMed ID: 17976259
[TBL] [Abstract][Full Text] [Related]
36. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.
Andrews GP; AbuDiak OA; Jones DS
J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757
[TBL] [Abstract][Full Text] [Related]
37. In-line implementation of an image-based particle size measurement tool to monitor hot-melt extruded pellets.
Treffer D; Wahl PR; Hörmann TR; Markl D; Schrank S; Jones I; Cruise P; Mürb RK; Koscher G; Roblegg E; Khinast JG
Int J Pharm; 2014 May; 466(1-2):181-9. PubMed ID: 24614578
[TBL] [Abstract][Full Text] [Related]
38. Solutions as solutions--synthesis and use of a liquid polyester excipient to dissolve lipophilic drugs and formulate sustained-release parenterals.
Asmus LR; Gurny R; Möller M
Eur J Pharm Biopharm; 2011 Nov; 79(3):584-91. PubMed ID: 21820511
[TBL] [Abstract][Full Text] [Related]
39. Chronotherapeutic Drug Delivery of Ketoprofen and Ibuprofen for Improved Treatment of Early Morning Stiffness in Arthritis Using Hot-Melt Extrusion Technology.
Dumpa NR; Sarabu S; Bandari S; Zhang F; Repka MA
AAPS PharmSciTech; 2018 Aug; 19(6):2700-2709. PubMed ID: 29968041
[TBL] [Abstract][Full Text] [Related]
40. Dissolution enhancement of itraconazole by hot-melt extrusion alone and the combination of hot-melt extrusion and rapid freezing--effect of formulation and processing variables.
Lang B; McGinity JW; Williams RO
Mol Pharm; 2014 Jan; 11(1):186-96. PubMed ID: 24283890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
